Dr. Biswa Prasun Chatterji

Dr. Biswa Prasun Chatterji


  • Faculty of Science


Name: Specialization:
Dr. Biswa Prasun Chatterji Biotechnology


PhD (2011), IIT Bombay

M.Tech Biotechnology (2002), Jadavpur University

M.Sc. Physiology (1999) University of Calcutta

Personal Interest

Reading, writing, singing

Working Experience

Associate Professor in School of Engineering, Ajeenkya DY Patil University, Pune, India (2017-2022)

Assistant Professor in PG Department of Biotechnology at St.Xavier’s College Mumbai,India (2012-2017)

Analyst in Dolcera ITES Pvt Ltd, Hyderabad,India (2011-2012)

Research Associate in the R&D Division of Maharashtra Hybrid Seeds Company Ltd (MAHYCO), Jalna, Maharashtra, India (2005-2006)

Lecturer in Biotechnology at Haldia Institute of Technology, Haldia, West Bengal, under West Bengal University of Technology,India (2004-2005)


Anticancer Drug discovery - microtubule targeted drug molecules

Xanthan Fermentation

Book Chapter
1. Needa Nasir, Riddhi Bhavsar and Chatterji BP (2017) Microtubules as Anticancer
Drug Target in an e-book “Topics in Anti-Cancer Research", pg 31-74, Volume 6, 2017
: Bentham Science Publishers; ( Invited book chapter)
2. Tanvi kaku, Aiswarya Dash and Biswa P Chatterji (2018) Taxol to Nanotaxol: A
Journey Towards Enhanced Drug Delivery. Topics in Anti-Cancer Research. vol 7,pg
1-23 Bentham Science Publishers; ( Invited book chapter)
Papers in International Journals
1. Swati Vatsya, Roza Parveen and Biswa Prasun Chatterji (2021) Toxicology of
Nanoparticles in Drug Delivery. Current Pathobiology Reports. 9, 133–144 Impact
factor 2.29
2. Sinha Debasmita and Chatterji Biswa Prasun (2021) India needs rigorously tested,
culturally adapted cognitive behavioural therapy. Lancet Psychiatry, VOLUME 8, ISSUE
5, P361-362 Impact Factor 77.05
3. Ghosh Madhurima & Chatterji Biswa Prasun. (2020) Mental health insurance in India
after COVID-19. Lancet Psychiatry, VOLUME 7, ISSUE 12, P1016-1017. Impact factor
4. De Souza, C., Lindstrom, A.R., Ma, Z. and Chatterji, B.P., 2020. Nanomaterials as
potential transporters of HDAC inhibitors. Medicine in Drug Discovery,
p.100040.Impact factor 2.6
5. Rashid A, Naaz A, Rai A, Chatterji BP, Panda D.(2019) Inhibition of polo-like kinase 1
suppresses microtubule dynamics in MCF-7 cells. Mol Cell Biochem. 2019 Nov 28. doi:
10.1007/s11010-019-03664-y. [Epub ahead of print] Impact factor 3.39
6. Biswa P. Chatterji, Godiwala Mehvash, Sunder Roma (2018) Ocular Stem Cells to Treat
Retinal and Corneal Disorders. The Open Stem Cell Journal. 5:31-46 Impact Factor 1.0
7. Chatterji,BP (2017) PhD Jobs: explore Posts Abroad. Nature. 551:440 Impact factor
8. Chatterji,BP (2017) Ingenious solutions sparked by a crisis. Nature. 548:281 Impact
factor 69.5
9. De.O and Chatterji BP (2017) Marine microtubule targeting anticancer drugs. Recent
Patents in Anticancer Drug Discovery. Vol 12, Issue 1, 102-127 Impact factor : 2.95
10. Agrawal M and Chatterji BP (2015) Patented small molecules used for reprogramming.
Current Regenerative Medicine, 5(2): 152-163.
11. DeSouza Cristabelle and Chatterji BP (2015) HDAC Inhibitors as Novel Anti-Cancer
Therapeutics. Recent Patents on Anti Cancer Drug Discovery. 10(2);145-162 Impact
factor : 4.16
12. Rai A, Kapoor S, Singh S, Chatterji BP, Panda D.(2015) Transcription factor NF-κB
associates with microtubules and stimulates apoptosis in response to suppression of
microtubule dynamics in MCF-7 cells. Biochem Pharmacol. 93(3):277-89 Impact factor
: 5.85
13. Srinivasan K and Chatterji BP (2014) Advances in cancer stem cells therapy : targets and
treatments. Recent Patents in Regenerative Medicine. 4:79-93
14. Bhargava S and Chatterji BP (2014) Tubulin as Vaccine Target. Intellectual Property
Rights Open Access. 2:124, impact factor 0.211
15. Chatterji BP (2014) India: Research Split harmed Universities. Nature 509:164 Impact
factor : 69.5
16. Chakraborti, Soumyananda; Chakravarty, Devlina; Gupta, Suvroma; Chatterji,
Biswaprasun; Dhar, Gopa; Poddar, Asim; Panda, Dulal; Chakrabarti, Pinak; Ghosh
Dastidar, Shubhra; Bhattacharyya, Bhabatarak. (2012) Discrimination of ligands of
different flexibility resulting from the plasticity of the binding site in tubulin.
Biochemistry. 51(36):7138-48 Impact factor : 2.93
17. Naik PK, Chatterji BP, Vangapandu SN, Aneja R, Chandra R, Kanteveri S, Joshi HC.
(2011) Rational design, synthesis and biological evaluations of amino-noscapine: a high
affinity tubulin-binding noscapinoid. J Comput Aided Mol Des. 25 (5):443-54. Impact
factor : 3.686
18. Chatterji BP, Jindal B, Srivastava S, Panda D. (2011) Microtubules as antifungal and
antiparasitic drug targets. Expert Opin Ther Pat. 21(2):167-86. Impact factor : 4.29
19. Chatterji BP, Banerjee M, Singh P, Panda D. (2010) HMBA depolymerizes microtubules,
activates mitotic checkpoints and induces mitotic block in MCF-7 cells by binding at the
colchicine site in tubulin. Biochem Pharmacol. 80(1):50-61. Impact factor : 5.85
20. Chatterji BP. (2010) On the discovery of the nature of cholera toxin in India. Vesalius.
16(1):16-8. SJR : 0.1
21. Chatterji BP. (2010) PhD: time and effort invested foster scientific maturity. Nature.
464(7290):831. Impact factor : 69.5
Conference Proceedings
1. Dr. Biswa Prasun Chatterji*, Dr. Ms. Vivien Amonkar, Asha Jose, Dency Almeida,
Karan Acharya Needa Nasir, Oindrila De, Rachel Agera and Ria Darne.(2016) Utility
of Xanthan Gum Produced from Agro Food Waste. Proceedings of the India
International science Festival –Young Scientists’ Meet; Department of Science &
technology, Govt of India-Dec 4-8, 2015. Paper code : waste 23

Awards & Achievements

Won a 2 nd Prize for an oral presentation in Waste to Wealth section of India International Science Festival (IISF) 2015 at IIT Delhi between 4th and 8th Dec 2015 on “Utility of Xanthan Gum from Agro Food Waste”

Editorial Board Member of International Journal of Advance Study and Research Work (ISSN:2581-5997) Editorial Board Member of Global Research and Development Journal For Engineering (ISSN: 2455-5703)